Elizabeth Hoge
CIK: 0002000987
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Hoge Elizabeth
Hoge Elizabeth (SEC CIK 0002000987) files insider reports with the SEC as 10% Owner of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 2 ownership filings by Hoge Elizabeth, all Form 4s, filed between Oct 15, 2024 and Apr 6, 2026. Those filings report 2 transactions, from Oct 11, 2024 to Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hoge Elizabeth's filings is in WASHINGTON, DC.
Recent filings by Hoge Elizabeth
Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)
- Kalayoglu Murat, 10% Owner
- Singer Michael, Director
- Brunn Carsten, President and CEO
- Miljkovic Milos, Chief Medical Officer
- Davis Blaine, Chief Financial Officer
- DeSilva Nishan M, Director